OPRK1 and heart failure: Following naltrexone treatment of ACF, rats’ myocardial expression of MOR, DOR, and KOR mRNAs was significantly downregulated—even beyond control values—which might be related to the previously demonstrated enhanced opioid peptide levels during volume overload-induced heart failure [5, 7].